Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Gaggiano

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Frontiers in Pediatrics|January 3, 2022
Toward the Knowledge of the Epidemiological Impact of Acute Rheumatic Fever in ItalyAntonino Maria Quintilio Alberio, Filippo Pieroni, Alessandro Di Gangi, et al.
Journal of Personalized Medicine|November 26, 2024
Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral CentersStefano Gentileschi, Carlo Cannistrà, Carla Gaggiano, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Doppler and Spectral Ultrasound of Sacroiliac Joints in Pediatric Patients with Suspected Juvenile SpondyloarthritisPaolo Falsetti, Edoardo Conticini, Carla Gaggiano, et al.
Internal and Emergency Medicine|December 21, 2022
The diagnostic role of pathergy test in patients with Behçet's disease from the Western EuropeAntonio Vitale, Virginia Berlengiero, Valeria Caggiano, et al.
Joint Bone Spine|September 14, 2024
Systemic auto-inflammatory manifestations in patients with spondyloarthritisCarla Gaggiano, Mojca Zajc Avramovič, Antonio Vitale, et al.
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Retention rate of IL-1 inhibitors in Schnitzler's syndromeFrancesca Crisafulli, Antonio Vitale, Paolo Airò, et al.
Internal and Emergency Medicine|April 9, 2021
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA networkJurgen Sota, Donato Rigante, Giuseppe Lopalco, et al.
Clinical and Experimental Medicine|February 5, 2025
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre studyCaterina Baldi, Stefano Gentileschi, Francesca Li Gobbi, et al.
Frontiers in Pharmacology|January 24, 2019
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Antonella Insalaco, Rolando Cimaz, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Pediatrics|January 3, 2022
Toward the Knowledge of the Epidemiological Impact of Acute Rheumatic Fever in ItalyAntonino Maria Quintilio Alberio, Filippo Pieroni, Alessandro Di Gangi, et al.
Journal of Personalized Medicine|November 26, 2024
Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral CentersStefano Gentileschi, Carlo Cannistrà, Carla Gaggiano, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Doppler and Spectral Ultrasound of Sacroiliac Joints in Pediatric Patients with Suspected Juvenile SpondyloarthritisPaolo Falsetti, Edoardo Conticini, Carla Gaggiano, et al.
Internal and Emergency Medicine|December 21, 2022
The diagnostic role of pathergy test in patients with Behçet's disease from the Western EuropeAntonio Vitale, Virginia Berlengiero, Valeria Caggiano, et al.
Joint Bone Spine|September 14, 2024
Systemic auto-inflammatory manifestations in patients with spondyloarthritisCarla Gaggiano, Mojca Zajc Avramovič, Antonio Vitale, et al.
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Retention rate of IL-1 inhibitors in Schnitzler's syndromeFrancesca Crisafulli, Antonio Vitale, Paolo Airò, et al.
Internal and Emergency Medicine|April 9, 2021
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA networkJurgen Sota, Donato Rigante, Giuseppe Lopalco, et al.
Clinical and Experimental Medicine|February 5, 2025
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre studyCaterina Baldi, Stefano Gentileschi, Francesca Li Gobbi, et al.
Frontiers in Pharmacology|January 24, 2019
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Antonella Insalaco, Rolando Cimaz, et al.
Pageof 9